b - Search

Clinical Trials

• B Cell Response to a Primary and a Booster Course of the Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants
  ClinicalTrials.gov Identifier: NCT00488683 - Recruiting
  Meningococcal Disease
  
• B Type Natriuretic Peptide for the Management of Weaning
  ClinicalTrials.gov Identifier: NCT00473148 - Recruiting
  Respiratory Insufficiency; Duration of Weaning From Invasive Ventilation
  
• B-19 Parvovirus Vaccine Study
  ClinicalTrials.gov Identifier: NCT00379938 - Suspended
  Parvovirus B19 Infection
  
• B-Left HF: Biventricular Versus Left Univentricular Pacing With Implantable Cardiac Defibrillator (ICD) Back-Up in Heart Failure Patients
  ClinicalTrials.gov Identifier: NCT00187213 - Active, not recruiting
  Heart Failure; Ventricular Dysfunction; Heart Diseases
  
• B-Lymphocyte Immunotherapy in Islet Transplantation
  ClinicalTrials.gov Identifier: NCT00468442 - Recruiting
  Type 1 Diabetes Mellitus
  
• B-Lymphocyte Stimulator (BLyStm) To Treat Selective IgA Deficiency
  ClinicalTrials.gov Identifier: NCT00024934 - Completed
  
  
• B-Type Natriuretic Peptide for Acute Shortness of Breath EvaLuation (BASEL) Study - Private Practice
  ClinicalTrials.gov Identifier: NCT00130611 - Active, not recruiting
  Acute dyspnoea
  
• B-Type Natriuretic Peptide in the Non-Cardiac Pediatric Patient
  ClinicalTrials.gov Identifier: NCT00330811 - Active, not recruiting
  Pediatric
  
• B14 Meningococcal Carriage in Seine-Maritime Population: Prevalence Study and Search of Risk Factors
  ClinicalTrials.gov Identifier: NCT00465582 - Recruiting
  Meningococcal Infections
  
• B181 Metobes-III: Weight Loss Maintenance of a New Bioactive Compound (Metobes-Long)
  ClinicalTrials.gov Identifier: NCT00302263 - Completed
  Obesity
  
• B181: Stimulation of Thermogenesis by Bio-Active Food Ingredients
  ClinicalTrials.gov Identifier: NCT00302289 - Completed
  Obesity
  
• B195: Effect of Diet-Induced Energy Deficit and Body Fat Reduction on Inflammatory Markers in Obese Subjects
  ClinicalTrials.gov Identifier: NCT00302926 - Completed
  Obesity
  
• B2-Adrenergic Receptor Polymorphisms
  ClinicalTrials.gov Identifier: NCT00279786 - Recruiting
  Status Asthmaticus
  
• Back Pain Prevalence in Wheelchair Users and Associated Risk Factors
  ClinicalTrials.gov Identifier: NCT00477568 - Recruiting
  Back Pain
  
• Backup With Combivir or Single Dose (Sd) Truvada in Order to Avoid NNRTI Resistance After Sd Nevirapine for the PMTCT
  ClinicalTrials.gov Identifier: NCT00346567 - Recruiting
  HIV
  
• BacLite Rapid MRSA Clinical Performance
  ClinicalTrials.gov Identifier: NCT00541632 - Enrolling by invitation
  Methicillin Resistance
  
• Baclofen Effects on Smoking Urge and Withdrawl
  ClinicalTrials.gov Identifier: NCT00257894 - Recruiting
  Smoking; Tobacco - Use Disorder; Nicotine Dependence; Nicotine - Use Disorder
  
• Baclofen for the Treatment of Cocaine Dependence - 1
  ClinicalTrials.gov Identifier: NCT00082485 - Active, not recruiting
  Cocaine-Related Disorders
  
• Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
  ClinicalTrials.gov Identifier: NCT00516503 - Not yet recruiting
  Neurotoxicity; Pain; Unspecified Adult Solid Tumor, Protocol Specific
  
• Bacteria Entering the Blood Stream From Tooth Extractions and Tooth Brushing
  ClinicalTrials.gov Identifier: NCT00454285 - Active, not recruiting
  Bacteremia
  
• Bacterial Contamination of Anaesthetists' Hands by Personal Mobile Phones Used in the Operating Theatre
  ClinicalTrials.gov Identifier: NCT00416936 - Completed
  Environmental Microbiology; Equipment Contamination; Personnel, Hospital
  
• Bacterial Control in Partial Thickness Burns Using Silver-Containing Wound Dressings
  ClinicalTrials.gov Identifier: NCT00343824 - Recruiting
  Burn Wounds - Partial Thickness (2nd Degree)
  
• Bacterial Interference for Prevention of Catheter-Associated UTI
  ClinicalTrials.gov Identifier: NCT00554996 - Not yet recruiting
  Catheter-Associated UTI
  
• Bacterial Pulmonary Infection in PICU
  ClinicalTrials.gov Identifier: NCT00271531 - Recruiting
  Bacterial Infection
  
• Bacterial Vaginosis Screening and Treatment to Reduce Infective Complications, Abortion and Preterm Delivery
  ClinicalTrials.gov Identifier: NCT00491270 - Not yet recruiting
  Vaginosis, Bacterial; Abortion, Spontaneous; Premature Birth
  
• Bacterial Vaginosis; A Randomized Trial to Reduce Recurrence
  ClinicalTrials.gov Identifier: NCT00542074 - Completed
  Bacterial Vaginosis
  
• Balance Control and Maturation in Normal and Deaf Children Aged from 6 to 14 Years Old
  ClinicalTrials.gov Identifier: NCT00140699 - Active, not recruiting
  Deaf children
  
• Balance Impairment and Falls Risk in People With Lower Limb Arthritis, and Can These be Improved With Exercise?
  ClinicalTrials.gov Identifier: NCT00527189 - Completed
  Arthritis
  
• Balance in Patients After Surgery for Torn Meniscus.
  ClinicalTrials.gov Identifier: NCT00256971 - Recruiting
  Torn Menisci
  
• Balance Recovery and Training on Fall Prevention in Stroke
  ClinicalTrials.gov Identifier: NCT00173992 - Not yet recruiting
  Stroke
  
• Balance Recovery and Training on Fall Prevention in Stroke
  ClinicalTrials.gov Identifier: NCT00166907 - Recruiting
  Stroke
  
• Balanced Anesthesia for Intubation of Premature Infants - a Randomized Intervention Study
  ClinicalTrials.gov Identifier: NCT00216944 - Recruiting
  Premature Birth
  
• Balloon Angioplasty Versus Xpert Stent in CLI Patients XXS Study
  ClinicalTrials.gov Identifier: NCT00546845 - Recruiting
  Cronic Limb Ishemia; Intervention
  
• Balloon Angioplasty vs. Cutting Balloon Angioplasty of Femoropopliteal Arteries- a Randomized Controlled Trial
  ClinicalTrials.gov Identifier: NCT00437905 - Terminated
  Peripheral Vascular Disease; Intermittent Claudication; Atherosclerosis; Angioplasty
  
• Balloon Prophylaxis of Aneurysmal Vasospasm
  ClinicalTrials.gov Identifier: NCT00282893 - Completed
  Aneurysm; Vasospasm
  
• Balloon Valvuloplasty Registry
  ClinicalTrials.gov Identifier: NCT00005199 - Completed
  Heart Diseases; Mitral Valve Stenosis; Aortic Valve Stenosis
  
• Balsalazide Disodium vs. Mesalamine in Mildly to Moderately Active Ulcerative Colitis
  ClinicalTrials.gov Identifier: NCT00408174 - Completed
  Inflammatory Bowel Disease; Ulcerative Colitis
  
• Banding Versus Propranolol for Primary Prophylaxis of Variceal Bleeding
  ClinicalTrials.gov Identifier: NCT00337740 - Recruiting
  Liver Cirrhosis; Esophageal Varices
  
• Bands in Peripheral Blood After Coronary Artery Bypass Grafting With and Without Cardiopulmonary Bypass
  ClinicalTrials.gov Identifier: NCT00563030 - Recruiting
  Neutrophils; Coronary Artery Bypass Graft Surgery; Inflammatory Response Syndrome, Systemic
  
• Bangkok Tenofovir Study
  ClinicalTrials.gov Identifier: NCT00119106 - Recruiting
  HIV Infections
  
• Bangladesh Vitamin E and Selenium Trial
  ClinicalTrials.gov Identifier: NCT00392561 - Recruiting
  Arsenical Skin Lesions
  
• Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation
  ClinicalTrials.gov Identifier: NCT00428233 - Recruiting
  Chronic Lymphocytic Leukemia
  
• Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00574132 - Recruiting
  Alzheimer's Disease
  
• Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00575055 - Recruiting
  Alzheimer's Disease
  
• Bardet-Biedl Syndrome Study: Clinical and Genetic Epidemiology Study in Adults
  ClinicalTrials.gov Identifier: NCT00213811 - Active, not recruiting
  Bardet-Biedl Syndrome; Orphan Diseases
  
• Bariatric Dose-Ranging Study With Dexmedetomidine
  ClinicalTrials.gov Identifier: NCT00363935 - Completed
  Abdominal Surgery Patients
  
• Bariatric Surgery for ESRD Patients vs Control
  ClinicalTrials.gov Identifier: NCT00580762 - Recruiting
  Obesity; ESRD
  
• Barley Protein and CVD
  ClinicalTrials.gov Identifier: NCT00334308 - Active, not recruiting
  Hypercholesterolemia; Cardiovascular Disease; Diet Therapy
  
• Barrett's Esophagus & Gastroesophageal Reflux Disease
  ClinicalTrials.gov Identifier: NCT00513331 - Recruiting
  Barrett's Esophagus; GERD
  
• Barrier Function and Production of Inflammatory Cytokines in the Rectal Mucosa in Patients With Septic Shock
  ClinicalTrials.gov Identifier: NCT00378586 - Not yet recruiting
  Septic Shock
  
• Barriers to Care for Harris County Cervical Cancer Patients or Patients With Precancerous Lesions (CIS)
  ClinicalTrials.gov Identifier: NCT00519272 - Recruiting
  Cervical Cancer
  
• Barriers to Effective Weight Loss in Overweight Adolescents
  ClinicalTrials.gov Identifier: NCT00562263 - Recruiting
  Overweight
  
• Barriers to Treatment in Obese Adolescents
  ClinicalTrials.gov Identifier: NCT00167830 - Active, not recruiting
  Obesity
  
• Basal Insulins - Pharmacodynamics
  ClinicalTrials.gov Identifier: NCT00566124 - Completed
  Diabetes
  
• Baseline Sexual Function, Cognitive Function, Body Composition and Muscle Parameters and Pharmacokinetics of Transdermal Testosterone Gel in Women with Hypopituitarism
  ClinicalTrials.gov Identifier: NCT00144404 - Recruiting
  Panhypopituitarism
  
• Baselines in Reproductive Disorders
  ClinicalTrials.gov Identifier: NCT00456274 - Recruiting
  Amenorrhea; Hypogonadotropic Hypogonadism; Kallmann's Syndrome
  
• BaSES Trial: Basel Starch Evaluation in Sepsis
  ClinicalTrials.gov Identifier: NCT00273728 - Recruiting
  Sepsis; Severe Sepsis; Septic Shock
  
• Basic Life Support Termination of Resuscitation Implementation Study
  ClinicalTrials.gov Identifier: NCT00370461 - Recruiting
  Cardiac Arrest
  
• Basic Mechanisms of Meditation and Cardiovascular Disease in Older Blacks
  ClinicalTrials.gov Identifier: NCT00010530 - Completed
  Cardiovascular Diseases
  
• BASIC: Boosted Atazanavir or Saquinavir Induced Lipid Changes
  ClinicalTrials.gov Identifier: NCT00389402 - Recruiting
  HIV Infections
  
• Basiliximab for the Treatment of Acute Graft-Versus-Host Disease After Allogeneic Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00563108 - Recruiting
  Graft vs Host Disease; Hematopoietic Stem Cell Transplantation
  
• Basiliximab in Moderate to Severe Ulcerative Colitis
  ClinicalTrials.gov Identifier: NCT00430898 - Recruiting
  Ulcerative Colitis
  
• BASTA Study on STI in HIV Infected Patients
  ClinicalTrials.gov Identifier: NCT00310245 - Completed
  HIV Infection
  
• Bathing persons with Alzheimer's disease aT Home (The BATH Study)
  ClinicalTrials.gov Identifier: NCT00062569 - Recruiting
  Alzheimer Disease
  
• Batracylin in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma
  ClinicalTrials.gov Identifier: NCT00450502 - Recruiting
  Lymphoma; Small Intestine Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• BATTLE Program: BAY43-9006 in Patients With NSCLC
  ClinicalTrials.gov Identifier: NCT00411671 - Recruiting
  Lung Cancer
  
• BATTLE Program: Tarceva and Targretin in Patients With NSCLC
  ClinicalTrials.gov Identifier: NCT00411632 - Recruiting
  Lung Cancer
  
• BATTLE Program: Tarceva in Previously Treated Subjects With Advanced NSCLC
  ClinicalTrials.gov Identifier: NCT00410059 - Recruiting
  Lung Cancer
  
• BATTLE Program: Umbrella Protocol for Patients With NSCLC
  ClinicalTrials.gov Identifier: NCT00409968 - Recruiting
  Lung Cancer
  
• BATTLE Program: ZD6474 in Previously Treated Subjects With NSCLC
  ClinicalTrials.gov Identifier: NCT00410189 - Recruiting
  Lung Cancer
  
• Bavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency Virus
  ClinicalTrials.gov Identifier: NCT00503347 - Recruiting
  Hepatitis C Virus; HIV Infections
  
• BAY 43-9006 (Sorafenib) and Bevacizumab (Avastin) To Treat Solid Tumors
  ClinicalTrials.gov Identifier: NCT00095459 - Recruiting
  Neoplasms
  
• BAY 43-9006 (Sorafenib) to Treat Relapsed Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00098254 - Recruiting
  
  
• BAY 43-9006 (Sorafenib) Versus Interferon Alpha-2a in Patients with Unresectable and/Or Metastatic Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00117637 - Completed
  Renal Cell Carcinoma; Neoplasm Metastasis
  
• BAY 43-9006 in Patients with Advanced Hepatocellular Carcinoma
  ClinicalTrials.gov Identifier: NCT00048919 - Completed
  Carcinoma, Hepatocellular
  
• BAY 43-9006 in Previously Untreated Patients With IIIB/IV NSCLC
  ClinicalTrials.gov Identifier: NCT00533585 - Recruiting
  Lung Cancer
  
• BAY 43-9006 in Treating Patients With Advanced Inoperable Liver Cancer
  ClinicalTrials.gov Identifier: NCT00058383 - No longer recruiting
  adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized unresectable adult primary liver cancer
  
• BAY 43-9006 in Treating Patients With Imatinib Mesylate-Resistant Chronic Phase Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00085007 - Active, not recruiting
  chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; relapsing chronic myelogenous leukemia
  
• BAY 43-9006 in Treating Patients With Refractory Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00064350 - Active, not recruiting
  recurrent non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer; ...
  
• BAY 56-3722 in Treating Patients With Recurrent, Unresectable, or Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00040989 - Terminated
  Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• BAY 59-7939 in the Extended Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Elective Total Hip Replacement (RECORD 1)
  ClinicalTrials.gov Identifier: NCT00329628 - Completed
  Thromboembolism
  
• BAY 59-8862 in Treating Patients With Advanced Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00039169 - Active, not recruiting
  stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• BAY 59-8862 in Treating Patients With Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00054314 - Completed
  recurrent non-small cell lung cancer
  
• BAY 59-8862 in Treating Patients With Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00039156 - Active, not recruiting
  recurrent grade III follicular large cell lymphoma; recurrent adult diffuse mixed cell lymphoma; recurrent adult diffuse large cell lymphoma; ...
  
• BAY-43-9006 in Advanced, Metastatic Soft Tissue Sarcomas
  ClinicalTrials.gov Identifier: NCT00406601 - Recruiting
  Sarcoma, Soft Tissue
  
• BAY12-8039 5 Days Sinusitis vs Placebo
  ClinicalTrials.gov Identifier: NCT00492024 - Recruiting
  Respiratory Tract Infection; Bacterial Sinusitis
  
• BB-10901 in Treating Patients With Recurrent or Refractory Lung Cancer, Metastatic Carcinoid Tumor, or Other Solid Tumors
  ClinicalTrials.gov Identifier: NCT00074256 - Recruiting
  adult solid tumor; gastrointestinal carcinoid tumor; Neuroendocrine Carcinoma; Non-small cell lung cancer; pulmonary carcinoid tumor; ...
  
• BB-10901 in Treating Patients With Relapsed and/or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00346255 - Recruiting
  Multiple Myeloma and Plasma Cell Neoplasm
  
• BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00346385 - Suspended
  Cervical Cancer; Gastrointestinal Carcinoid Tumor; Lung Cancer; Sarcoma; Unspecified Adult Solid Tumor, Protocol Specific
  
• BBC ONE - British Bifurcation Coronary Study
  ClinicalTrials.gov Identifier: NCT00351260 - Recruiting
  Ischaemic Heart Disease; Stenosis; Angina
  
• BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL)
  ClinicalTrials.gov Identifier: NCT00088530 - Recruiting
  Lymphoma, Non-Hodgkin
  
• BBR 3464 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Cannot be Treated With Surgery
  ClinicalTrials.gov Identifier: NCT00024362 - Active, not recruiting
  stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
  
• BBR 3464 in Treating Patients With Metastatic Small Cell Lung Cancer That Has Not Responded to Previous Treatment
  ClinicalTrials.gov Identifier: NCT00014547 - Active, not recruiting
  extensive stage small cell lung cancer; Recurrent Small Cell Lung Cancer
  
• BC-DAISY: A Breast Cancer Decision Aid System
  ClinicalTrials.gov Identifier: NCT00347568 - Active, not recruiting
  Breast Cancer
  
• BCG Plus Interferon alfa 2b in Treating Patients With Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00004122 - Completed
  transitional cell carcinoma of the bladder; stage I bladder cancer; recurrent bladder cancer; Quality of Life
  
• BCG Vaccine and Morbidity from Malaria.
  ClinicalTrials.gov Identifier: NCT00131794 - Completed
  Malaria
  
• BCG Vaccine Oral Intradermal
  ClinicalTrials.gov Identifier: NCT00396370 - Suspended
  Tuberculosis
  
• BCG With or Without Gefitinib in Treating Patients With High-Risk Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00352079 - Recruiting
  Bladder Cancer
  
• BCG With or Without Mitomycin in Treating Patients With Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00023842 - Active, not recruiting
  stage 0 bladder cancer; recurrent bladder cancer; transitional cell carcinoma of the bladder
  
• Bcl-2 Antisense Oligodeoxynucleotide G3139 and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00005032 - Active, not recruiting
  Recurrent Small Cell Lung Cancer
  
• BCX-1777 in Treating Patients With Refractory Cancer
  ClinicalTrials.gov Identifier: NCT00073944 - Active, not recruiting
  central nervous system cancer; female reproductive cancer; Gastrointestinal Cancer; hematopoietic and lymphoid cancer; skin tumor
  
• BCX-1777 in Treating Patients With Refractory Cutaneous T-Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00061880 - Active, not recruiting
  Cutaneous T-Cell Lymphoma; mycosis fungoides and Sezary syndrome
  
• BDNF Gene Polymorphism and Antidepressants Treatment
  ClinicalTrials.gov Identifier: NCT00308893 - Recruiting
  Depression
  
• Be SMART NIS, Moderate to Servere Asthma Patient Observation
  ClinicalTrials.gov Identifier: NCT00514787 - Recruiting
  Asthma
  
• BEAM+131I-Anti-B1 & Autologous Hematopoietic Stem Cell Transplant for Recurrent Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00574509 - Active, not recruiting
  Lymphoma
  
• BEATRICE Study: A Study of Avastin (Bevacizumab) Adjuvant Therapy in Triple Negative Breast Cancer.
  ClinicalTrials.gov Identifier: NCT00528567 - Recruiting
  Breast Cancer
  
• BEATRIS Study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis
  ClinicalTrials.gov Identifier: NCT00545909 - Active, not recruiting
  Post-Menopausal Osteoporosis
  
• Beclomethasone in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant for Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00489203 - Recruiting
  Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon
  ClinicalTrials.gov Identifier: NCT00010283 - Active, not recruiting
  Leukemia; Testicular Cancer; ovarian epithelial cancer; Lymphoma; Breast Cancer; Multiple Myeloma; kidney tumor
  
• Beclomethasone Plus Prednisone in Treating Patients With Graft-Versus-Host Disease
  ClinicalTrials.gov Identifier: NCT00043147 - Completed
  Graft Versus Host Disease
  
• Bed Rest for Idiopathic Sudden Sensorineural Hearing Loss
  ClinicalTrials.gov Identifier: NCT00416143 - Recruiting
  Sudden Loss of Hearing
  
• Bedside Silo Versus Operative Closure for Gastroschisis
  ClinicalTrials.gov Identifier: NCT00404690 - Recruiting
  Gastroschisis
  
• Behavior and Driving Safety Study
  ClinicalTrials.gov Identifier: NCT00575679 - Not yet recruiting
  Alcoholic Intoxication
  
• Behavior and Naltrexone Treatment for Alcoholics
  ClinicalTrials.gov Identifier: NCT00000449 - Completed
  Alcoholism
  
• Behavior Change and Maintenance Intervention for HIV+ MSM Methamphetamine Users
  ClinicalTrials.gov Identifier: NCT00432926 - Recruiting
  HIV Infections; Substance Abuse; Sexually Transmitted Diseases
  
• Behavior Enhances Drug Reduction of Incontinence (BE-DRI)
  ClinicalTrials.gov Identifier: NCT00090584 - Completed
  Urinary Incontinence
  
• Behavior in Children with Attention Deficit Hyperactivity Disorder and in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00026546 - Active, not recruiting
  Attention Deficit Hyperactivity Disorder
  
• Behavior of Children Related to Numbness After Dental Local Anesthesia
  ClinicalTrials.gov Identifier: NCT00363207 - Recruiting
  Anesthesia, Local; Anesthesia, Dental
  
• Behavior Therapy for Children and Adolescents with Obsessive-Compulsive Disorder (OCD)
  ClinicalTrials.gov Identifier: NCT00000386 - Completed
  Obsessive-Compulsive Disorder
  
• Behavior Therapy for Families of Diabetic Adolescents
  ClinicalTrials.gov Identifier: NCT00358059 - Completed
  Type 1 Diabetes Mellitus
  
• Behavior-Based Dietary Intervention in Treating Patients With Hormone-Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00082732 - Active, not recruiting
  stage I prostate cancer; stage II prostate cancer; adenocarcinoma of the prostate
  
• Behavioral & Nutritional Treatment to Help CF Preschoolers Grow
  ClinicalTrials.gov Identifier: NCT00241969 - Recruiting
  Cystic Fibrosis; Pancreatic Cystic Fibrosis
  
• Behavioral and Immunological Factors in Coronary Disease
  ClinicalTrials.gov Identifier: NCT00037284 - Active, not recruiting
  Cardiovascular Diseases; Coronary Disease; Heart Diseases; Depression
  
• Behavioral and Pharmacological Treatment for Insomnia
  ClinicalTrials.gov Identifier: NCT00042146 - Completed
  Sleep Initiation and Maintenance Disorders; Sleep Disorders, Intrinsic
  
• Behavioral and Physiological Effects of Visual Training
  ClinicalTrials.gov Identifier: NCT00526942 - Recruiting
  Healthy
  
• Behavioral Counseling for Alcohol Dependent Smokers (nicotine patch)
  ClinicalTrials.gov Identifier: NCT00004551 - Completed
  Alcoholism; Smoking
  
• Behavioral Economics of Human Drug Self-Administration
  ClinicalTrials.gov Identifier: NCT00005765 - Completed
  Drug Dependence
  
• Behavioral Effects of Obstructive Sleep Apnea in Children
  ClinicalTrials.gov Identifier: NCT00060723 - Active, not recruiting
  Sleep-Disordered Breathing; Sleep Apnea, Obstructive; ADHD
  
• Behavioral Factors in Coronary Heart Disease
  ClinicalTrials.gov Identifier: NCT00005314 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Coronary Disease; Metabolic Syndrome X
  
• Behavioral Health Services for Women Receiving Public Assistance
  ClinicalTrials.gov Identifier: NCT00057655 - Completed
  Mental Disorders
  
• Behavioral Indicators of Pain:Tool Development With Concurrent and Construct Validity
  ClinicalTrials.gov Identifier: NCT00208052 - Completed
  Pain
  
• Behavioral Insomnia Therapy for Fibromyalgia
  ClinicalTrials.gov Identifier: NCT00000397 - Completed
  Fibromyalgia; Insomnia
  
• Behavioral Insomnia Therapy in Primary Care
  ClinicalTrials.gov Identifier: NCT00105872 - Completed
  Insomnia
  
• Behavioral Insomnia Therapy With Chronic Fatigue Syndrome
  ClinicalTrials.gov Identifier: NCT00540254 - Recruiting
  Chronic Fatigue Syndrome; Behavioral Therapy Targeted to Sleep Problems
  
• Behavioral Intervention For BMT/SCT Survivors
  ClinicalTrials.gov Identifier: NCT00579917 - Recruiting
  Hodgkin's Disease; Leukemia; Multiple Myeloma; Non-Hodgkin's Lymphoma
  
• Behavioral Intervention for HIV and HCV-Uninfected Injection Drug Users
  ClinicalTrials.gov Identifier: NCT00164372 - Active, not recruiting
  HIV Infections; Hepatitis C
  
• Behavioral Intervention Trial for HIV-Infected Injection Drug Users
  ClinicalTrials.gov Identifier: NCT00146445 - Active, not recruiting
  Peer Mentoring Intervention; Video & Discussion Intervention (comparison condition)
  
• Behavioral Interventions for Control of TB
  ClinicalTrials.gov Identifier: NCT00005739 - Completed
  Lung Diseases; Tuberculosis
  
• Behavioral Interventions for Control of Tuberculosis
  ClinicalTrials.gov Identifier: NCT00005742 - Completed
  Lung Diseases; Tuberculosis
  
• Behavioral Naltrexone Therapy (BNT) for Promoting Adherence to Oral Naltrexone (BNT-Oral) vs Extended Release Injectable Depot Naltrexone (Depot-BNT); a Randomized Trial. A Free Treatment for Opiate Abuse.
  ClinicalTrials.gov Identifier: NCT00577408 - Recruiting
  Opiate Dependence; Heroin Dependence
  
• Behavioral Naltrexone Therapy: A Novel Treatment for Heroin Dependence
  ClinicalTrials.gov Identifier: NCT00332228 - Active, not recruiting
  Opiate Dependence
  
• Behavioral Processes Underlying Reward Processing in Depression
  ClinicalTrials.gov Identifier: NCT00205933 - Completed
  Major Depressive Disorder; Bipolar Disorder
  
• Behavioral Self-Regulation
  ClinicalTrials.gov Identifier: NCT00488228 - Active, not recruiting
  Obesity
  
• Behavioral Sleep Intervention in Adult Family Homes
  ClinicalTrials.gov Identifier: NCT00393627 - Recruiting
  Dementia
  
• Behavioral Strategies for Weight Management
  ClinicalTrials.gov Identifier: NCT00575731 - Active, not recruiting
  Obesity
  
• Behavioral Therapy Combined With Carbidopa/Levodopa for the Treatment of Cocaine Dependence
  ClinicalTrials.gov Identifier: NCT00218075 - Active, not recruiting
  Cocaine Abuse; Cocaine-Related Disorders
  
• Behavioral Therapy Development for Methamphetamine Abuse
  ClinicalTrials.gov Identifier: NCT00252434 - Recruiting
  Depression; Drug Abuse; Sexually Transmitted Diseases
  
• Behavioral Therapy for Reduction in Smoking Craving
  ClinicalTrials.gov Identifier: NCT00449293 - Active, not recruiting
  Smoking Cessation; Tobacco Dependence
  
• Behavioral Therapy Plus Naltrexone for Alcoholism
  ClinicalTrials.gov Identifier: NCT00000456 - Completed
  Alcoholism
  
• Behavioral Treatment of Drug Abuse in SPMI Patients
  ClinicalTrials.gov Identifier: NCT00295139 - Recruiting
  Schizophrenia; Mood Disorders; Substance Dependence
  
• Behavioral Treatment of Fibromyalgia
  ClinicalTrials.gov Identifier: NCT00000398 - Completed
  Fibromyalgia
  
• Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
  ClinicalTrials.gov Identifier: NCT00050622 - Completed
  Attention Deficit Hyperactivity Disorder
  
• Behavioral Treatments for Acute Stress Disorder In Firefighters
  ClinicalTrials.gov Identifier: NCT00183508 - Active, not recruiting
  Stress Disorders, Post-Traumatic
  
• Behavioral Treatments for Chronic Pain
  ClinicalTrials.gov Identifier: NCT00371865 - Recruiting
  Intractable Pain
  
• Behavioral, Clinical and Basic Science Studies of Non-Occupational Post-Exposure Prophylaxis ("PEP-2")
  ClinicalTrials.gov Identifier: NCT00473018 - Completed
  HIV Infections
  
• Behavioral/Drug Therapy for Alcohol-Nicotine Dependence (naltrexone/nicotine patch)
  ClinicalTrials.gov Identifier: NCT00000447 - Completed
  Alcoholism; Smoking
  
• Behavioural Intervention for Dysphagia in Acute Stroke
  ClinicalTrials.gov Identifier: NCT00257764 - Completed
  Dysphagia
  
• Behavioural Treatment of Hypertension
  ClinicalTrials.gov Identifier: NCT00247910 - Recruiting
  Hypertension
  
• Belatacept Evaluation of Nephroprotection and Efficacy as First-Line Immunosupression (BENEFIT)
  ClinicalTrials.gov Identifier: NCT00256750 - Active, not recruiting
  Kidney Transplantation; Chronic Kidney Failure
  
• Belatacept in Liver Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00555321 - Recruiting
  Immunosuppression in Solid Organ Transplant
  
• Belatacept Pharmacokinetic Trial in Renal Transplantation
  ClinicalTrials.gov Identifier: NCT00578448 - Not yet recruiting
  Renal Transplantation
  
• Belatacept Post Depletional Repopulation to Facilitate Tolerance
  ClinicalTrials.gov Identifier: NCT00565773 - Not yet recruiting
  Organ Transplantation
  
• Belatacept to Prevent Organ Rejection in Kidney Transplant Patients
  ClinicalTrials.gov Identifier: NCT00346151 - Recruiting
  Transplantation, Kidney; End-Stage Renal Disease
  
• Belgian Prospective Multicentre Registry on the Performance of the Smart Stent in the Superficial Femoral Artery According to the New Tasc II-Classification
  ClinicalTrials.gov Identifier: NCT00496041 - Recruiting
  Peripheral Vascular Disease
  
• BELIEVE Study: Nesiritide and Post Myocardial Infarction Left Ventricular Modeling
  ClinicalTrials.gov Identifier: NCT00252213 - Active, not recruiting
  Myocardial Infarction
  
• Belotecan (CKD-602) in Recurrent or Progressive Carcinoma of Uterine Cervix
  ClinicalTrials.gov Identifier: NCT00430144 - Recruiting
  Cervical Cancer
  
• Below Study - Balloonangioplasty or Stents with ReoPro for Prevention of Subacute Reocclusion in Arteries Below the Knee
  ClinicalTrials.gov Identifier: NCT00163254 - Active, not recruiting
  Patients above 18 years
  
• Beluga - Clinical Observations of Automatic Algorithms for Cardiac Pacing
  ClinicalTrials.gov Identifier: NCT00286858 - Recruiting
  Bradycardia; Sick Sinus Syndrome; Heart Block
  
• Bemiparin Randomized Trial on Bridging Oral Anticoagulants in Invasive Procedures (BERTA Study)
  ClinicalTrials.gov Identifier: NCT00484822 - Recruiting
  Long-Term Oral Anticoagulant Therapy
  
• Benazepril for Advanced Chronic Renal Insufficiency
  ClinicalTrials.gov Identifier: NCT00270426 - Terminated
  Chronic Kidney Failure
  
• Benchmarking Initiative to Reduce Bronchopulmonary Dysplasia
  ClinicalTrials.gov Identifier: NCT00067613 - Active, not recruiting
  Bronchopulmonary Dysplasia
  
• Bendamustin Hydrochloride in Patients With Soft Tissue Sarcoma (STS)
  ClinicalTrials.gov Identifier: NCT00204620 - Completed
  Sarcoma, Soft Tissue
  
• Bendamustine and Bortezomib Combination Therapy in Indolent NHL
  ClinicalTrials.gov Identifier: NCT00426855 - Recruiting
  Lymphoma, Non-Hodgkin
  
• Bendamustine and Mitoxantrone in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00274963 - Recruiting
  Leukemia
  
• Bendamustine and Rituximab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00274989 - Recruiting
  Leukemia
  
• Bendamustine in Treating Patients With Rituximab-Refractory Indolent B-Cell Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00085033 - Completed
  adult non-Hodgkin's lymphoma; indolent or aggressive adult non-Hodgkin's lymphoma
  
• Beneficial Bacteria to Prevent and Malnutrition and Diarrhea in Pakistinian Infants
  ClinicalTrials.gov Identifier: NCT00118872 - Recruiting
  Malnutrition; Diarrhea
  
• Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
  ClinicalTrials.gov Identifier: NCT00014989 - Active, not recruiting
  Cerebral Palsy; Intraventricular hemorrhage; Periventricular Leukomalacia; Pulmonary Edema; Abruptio Placentae
  
• Beneficial Effects of Oral Premarin Estrogen Replacement Therapy Assessed by Human Genome Array
  ClinicalTrials.gov Identifier: NCT00318318 - Active, not recruiting
  Healthy; Estrogen Replacement Therapy
  
• BENEFIT Extension Study
  ClinicalTrials.gov Identifier: NCT00544037 - Recruiting
  Multiple Sclerosis
  
• Benefit of a Collaborative Approach to Improve the Quality of Medicines Use in Elderly Inpatients
  ClinicalTrials.gov Identifier: NCT00279656 - Completed
  Frail Elderly Inpatient
  
• Benefit of Adding Chemotherapy And/Or Modification of Radiotherapy Schedule for Advance Nasopharyngeal Carcinoma (T3-4N0-1M0)
  ClinicalTrials.gov Identifier: NCT00563862 - Terminated
  Nasopharyngeal Neoplasms; Carcinoma, Squamous Cell
  
• Benefit of Adding Chemotherapy for Advance Nasopharyngeal Carcinoma (T1-4N2-3M0)
  ClinicalTrials.gov Identifier: NCT00563927 - Active, not recruiting
  Nasopharyngeal Neoplasms; Carcinoma, Squamous Cell
  
• Benefit of Adding Trastuzumab to Second Line Chemotherapy in Breast Cancer Patients Previously Treated with Trastuzumab.
  ClinicalTrials.gov Identifier: NCT00130507 - Suspended
  Breast Cancer
  
• Benefit of Changing Chemoradiotherapy Sequence and Modifying Radiotherapy Schedule for Advanced Nasopharyngeal Cancer
  ClinicalTrials.gov Identifier: NCT00577057 - Not yet recruiting
  Nasopharyngeal Neoplasms
  
• Benefit of Immunoprophylaxis on Fibrosis to Reduce Viral Load After Liver Transplantation
  ClinicalTrials.gov Identifier: NCT00538265 - Recruiting
  Liver Transplantation
  
• Benefit of Lidocaine Perfusion in Cancer Related Visceral Pain Resistant to Morphinics
  ClinicalTrials.gov Identifier: NCT00181012 - Recruiting
  Cancer; Pain
  
• Benefit of Self-Monitoring of Anticoagulation Instrument
  ClinicalTrials.gov Identifier: NCT00506870 - Recruiting
  Mechanical Prosthetic Heart Valve Implantation; Patient Self Monitoring of Oral Anticoagulent Therapy
  
• Benefit of SeptiFast Multiplex PCR in the Etiologic Diagnosis and Therapeutic Approach for Onco-Hematology Patients Presenting Sepsis
  ClinicalTrials.gov Identifier: NCT00561639 - Not yet recruiting
  Hematologic Diseases; Sepsis
  
• Benefits and Risks of Newborn Screening for Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00014950 - Completed
  Cystic Fibrosis; Lung Disease; Pseudomonas Infections
  
• Benefits of 'Repeat Back' Protocols Within A Computer-Based Informed Consent Program
  ClinicalTrials.gov Identifier: NCT00288899 - Recruiting
  Surgery; Cholecystectomy, Laparoscopic; Prostatectomy; Arthroplasty, Replacement, Hip; Endarterectomy, Carotid
  
• Benefits of Applying Neuroprosthesis for Improving Reaching and Grasping Functions in Stroke Patients
  ClinicalTrials.gov Identifier: NCT00221078 - Active, not recruiting
  -Stroke
  
• Benefits of Applying Neuroprosthesis to Improve Grasping and Reaching in Spinal Cord Injury Patients
  ClinicalTrials.gov Identifier: NCT00221117 - Recruiting
  Spinal Cord Injuries
  
• Benefits of Exercise and Education for Individuals With Parkinson's Disease (BEEP)
  ClinicalTrials.gov Identifier: NCT00167453 - Completed
  Parkinson Disease
  
• Benefits of Lightweight Ambulatory Oxygen Systems for Individuals With Chronic Obstructive Pulmonary Disease (COPD) Who Need Supplemental Oxygen
  ClinicalTrials.gov Identifier: NCT00325754 - Active, not recruiting
  Pulmonary Disease, Chronic Obstructive
  
• Benefits of Switching Antidepressants Following Early Nonresponse
  ClinicalTrials.gov Identifier: NCT00519012 - Recruiting
  Depression
  
• Benefits of Tanning in Fibromyalgia Patients
  ClinicalTrials.gov Identifier: NCT00447083 - Completed
  Fibromyalgia Syndrome
  
• Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets
  ClinicalTrials.gov Identifier: NCT00442325 - Completed
  Coronary Arteriosclerosis; Diabetes Mellitus, Type 2; Cerebrovascular Accident; Dyslipidemia; Peripheral Vascular Disease
  
• Benfotiamine in Diabetic Nephropathy
  ClinicalTrials.gov Identifier: NCT00565318 - Not yet recruiting
  Diabetic Nephropathy
  
• Benign Prostatic Hyperplasia Trial With Avodart And Tamsulosin Combination Treatment
  ClinicalTrials.gov Identifier: NCT00090103 - Active, not recruiting
  Benign Prostatic Hyperplasia
  
• Benzamide Derivates as Treatment of Clozapine-Induced Hypersalivation
  ClinicalTrials.gov Identifier: NCT00534573 - Not yet recruiting
  Clozapine-Induced Hypersalivation
  
• Benzene Exposure as a Risk Factor for Hematological Cancer or Related Disorders or Lung Cancer in Chinese Workers
  ClinicalTrials.gov Identifier: NCT00516568 - Not yet recruiting
  Leukemia; Lung Cancer; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Benzocaine Gel Toothache Dose-Response Study
  ClinicalTrials.gov Identifier: NCT00474175 - Recruiting
  Toothache
  
• Benzoylphenylurea in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00010205 - Completed
  unspecified adult solid tumor, protocol specific
  
• Benzoylphenylurea in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00016354 - Completed
  unspecified adult solid tumor, protocol specific
  
• Berlin Deep Brain Stimulation Depression Study
  ClinicalTrials.gov Identifier: NCT00531726 - Recruiting
  Therapy Resistant Major Depression
  
• Beryllium Infliximab Study: Clinical Interventional Trial
  ClinicalTrials.gov Identifier: NCT00111917 - Recruiting
  Berylliosis; Beryllium Disease
  
• BEST (Burn Center Evaluation of Standard Therapies) Ventilator Mode Study-
  ClinicalTrials.gov Identifier: NCT00351741 - Recruiting
  Burns
  
• Best Bypass Surgery (BBS) Trial
  ClinicalTrials.gov Identifier: NCT00120991 - Active, not recruiting
  Heart Disease; Cardiovascular Disease
  
• Beta Alethine in Treating Patients With Low-Grade Lymphoma
  ClinicalTrials.gov Identifier: NCT00007839 - Active, not recruiting
  Lymphoma
  
• Beta Alethine in Treating Patients With Myeloma
  ClinicalTrials.gov Identifier: NCT00006466 - Active, not recruiting
  monoclonal gammopathy of undetermined significance; stage I multiple myeloma; stage II multiple myeloma; extramedullary plasmacytoma; ...
  
• Beta Alethine in Treating Patients With Waldenstrom's Macroglobulinemia
  ClinicalTrials.gov Identifier: NCT00041379 - Active, not recruiting
  Waldenstrom's Macroglobulinemia
  
• Beta Blockade in Critical Injury
  ClinicalTrials.gov Identifier: NCT00356187 - Recruiting
  Trauma
  
• Beta Blocker for Chronic Wound Healing
  ClinicalTrials.gov Identifier: NCT00368602 - Recruiting
  Ulcer; Burns
  
• Beta Blockers Versus Variceal Band Ligation and Beta Blockers for Primary Prophylaxis of Variceal Bleeding
  ClinicalTrials.gov Identifier: NCT00409084 - Recruiting
  Esophageal Varices
  
• Beta Carotene From Natural Source for Patients With Non-Active Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00275418 - Recruiting
  Crohn's Disease
  
• Beta Cell Function in Women With Turner Syndrome
  ClinicalTrials.gov Identifier: NCT00419107 - Active, not recruiting
  Turner Syndrome
  
• Beta Cell Function Tests Over Time In Patients With T2dm Randomized To Metformin Or Rosiglitazone
  ClinicalTrials.gov Identifier: NCT00282945 - Terminated
  Type 2 Diabetes Mellitus
  
• Beta-2 Polymorphisms and Beta Receptor Selectivity
  ClinicalTrials.gov Identifier: NCT00214318 - Completed
  Heart Failure
  
• Beta-Blocker Before Extubation
  ClinicalTrials.gov Identifier: NCT00563238 - Recruiting
  Myocardial Ischemia
  
• Beta-Blocker Continuation Versus Interruption in Heart Failure Worsening
  ClinicalTrials.gov Identifier: NCT00162565 - Recruiting
  Heart Failure,Congestive; beta-Adrenergic Blockers
  
• Beta-Blocker Evaluation in Survival Trial (BEST)
  ClinicalTrials.gov Identifier: NCT00000560 - Completed
  Cardiovascular Diseases; Heart Diseases; Heart Failure, Congestive; Heart Failure
  
• Beta-Blocker Heart Attack Trial (BHAT)
  ClinicalTrials.gov Identifier: NCT00000492 - Completed
  Arrhythmia; Cardiovascular Diseases; Coronary Disease; Death, Sudden, Cardiac; Heart Diseases; Myocardial Infarction; Myocardial Ischemia; ...
  
• Beta-Carotene and Alpha-Tocopherol Chemoprevention of Second Primary Malignancies in Head and Neck Cancer Patients
  ClinicalTrials.gov Identifier: NCT00169845 - Active, not recruiting
  Neoplasms
  
• Beta-Cell Function and Sitagliptin Trial (BEST)
  ClinicalTrials.gov Identifier: NCT00420511 - Recruiting
  Type 2 Diabetes Mellitus
  
• Beta-CIT-SPECT and Neurophysiology in Depression
  ClinicalTrials.gov Identifier: NCT00145132 - Recruiting
  Depression
  
• Beta-Glucan and Monoclonal Antibody 3F8 in Treating Patients With Metastatic Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00492167 - Recruiting
  Neuroblastoma
  
• beta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00037011 - Active, not recruiting
  disseminated neuroblastoma; recurrent neuroblastoma
  
• Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00087009 - Recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma
  
• Beta-hCG + Erythropoietin in Acute Stroke
  ClinicalTrials.gov Identifier: NCT00362414 - Recruiting
  Acute Stroke
  
• Betaferon®/ Betaseron® (Interferon Beta-1b) in Patients With Chronic Viral Cardiomyopathy
  ClinicalTrials.gov Identifier: NCT00185250 - Completed
  Cardiomyopathies; Heart Diseases
  
• Betamethasone Dosing Interval - 12 or 24 Hours?
  ClinicalTrials.gov Identifier: NCT00453141 - Recruiting
  Preterm Delivery
  
• Betaseron 16-Year Long-Term Follow-Up (LTF) in Patients With Relapsing-Remitting Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00206635 - Completed
  Multiple Sclerosis
  
• Betaseron Pregnancy Registry
  ClinicalTrials.gov Identifier: NCT00317564 - Recruiting
  Birth Defects; Pregnancy Complications; Multiple Sclerosis
  
• Better Adherence to Therapeutic Lifestyle Change Efforts Trial
  ClinicalTrials.gov Identifier: NCT00458874 - Recruiting
  Cardiovascular Disease
  
• Better Asthma Outcomes: Lowering Tobacco Smoke Exposure
  ClinicalTrials.gov Identifier: NCT00217958 - Active, not recruiting
  Lung Diseases; Asthma
  
• Better Days, Better Nights: Treatment for Sleep Difficulties
  ClinicalTrials.gov Identifier: NCT00338429 - Recruiting
  Sleep Onset Latency and/or Bedtime Resistance
  
• Better Pediatric Asthma Outcomes Through Chronic Care
  ClinicalTrials.gov Identifier: NCT00355069 - Active, not recruiting
  Asthma
  
• Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma
  ClinicalTrials.gov Identifier: NCT00137826 - Active, not recruiting
  Mesothelioma
  
• Bevacizumab + CHOP-Rituximab in Untreated Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00401817 - Recruiting
  Untreated Mantle Cell Lymphoma
  
• BEVACIZUMAB + LETROZOL vs LETROZOL as First Line Treatment in Postmenopausal Patients With Advanced or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00545077 - Not yet recruiting
  Breast Cancer
  
• Bevacizumab and Abraxane as Second-Line Therapy in Triple Negative Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00472693 - Recruiting
  Breast Cancer
  
• Bevacizumab and AZD2171 in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma
  ClinicalTrials.gov Identifier: NCT00458731 - Recruiting
  Lymphoma; Small Intestine Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• Bevacizumab and Bortezomib in Patients With Advanced Malignancy
  ClinicalTrials.gov Identifier: NCT00428545 - Recruiting
  Advanced Malignancy; Lymphoma; Myeloma; Solid Tumors
  
• Bevacizumab and Capecitabine as First-Line Therapy in Treating Older Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00107315 - Recruiting
  recurrent colon cancer; stage IV colon cancer; recurrent rectal cancer; Stage IV rectal cancer
  
• Bevacizumab and Carboplatin/Paclitaxel and Radiation in Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00578149 - Completed
  Non-Small Cell Lung Cancer
  
• Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00193219 - Recruiting
  Colon Cancer
  
• Bevacizumab and Cetuximab With or Without Irinotecan in Treating Patients With Irinotecan-Refractory Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00077298 - Completed
  stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer
  
• Bevacizumab and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00335829 - Recruiting
  Liver Cancer
  
• Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00423696 - Recruiting
  Colorectal Cancer
  
• Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00467142 - Recruiting
  Colorectal Cancer
  
• Bevacizumab and Combination Chemotherapy in Patients With Hematologic Cancers
  ClinicalTrials.gov Identifier: NCT00217425 - Recruiting
  anaplastic large cell lymphoma; stage I adult T-cell leukemia/lymphoma; stage II adult T-cell leukemia/lymphoma; ...
  
• Bevacizumab and Combination Chemotherapy in Treating Patients Who Have Undergone Surgery for Breast Cancer That Has Spread to the Lymph Nodes
  ClinicalTrials.gov Identifier: NCT00119262 - Active, not recruiting
  stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; Male Breast Cancer
  
• Bevacizumab and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00544011 - Recruiting
  Colorectal Cancer
  
• Bevacizumab and Combination Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00128674 - Recruiting
  stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
  
• Bevacizumab and Docetaxel in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00541099 - Not yet recruiting
  Lung Cancer
  
• Bevacizumab and Docetaxel in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00504257 - Recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Bevacizumab and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00055861 - Completed
  recurrent breast cancer; stage IV breast cancer
  
• Bevacizumab and Doxorubicin Hydrochloride Liposome in Treating Women With Locally Recurrent or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00445406 - Recruiting
  Breast Cancer
  
• Bevacizumab and Erlotinib Followed by Cisplatin or Carboplatin and Gemcitabine in Treating Patients With Newly Diagnosed or Recurrent Stage IIIB or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00354549 - Recruiting
  Lung Cancer
  
• Bevacizumab and Erlotinib in Inoperable and Metastatic Hepatocellular Carcinoma
  ClinicalTrials.gov Identifier: NCT00287222 - Recruiting
  Hepatocellular Carcinoma
  
• Bevacizumab and Erlotinib in the Treatment of Patients With Carcinoma of Unknown Primary Site
  ClinicalTrials.gov Identifier: NCT00193622 - Active, not recruiting
  Neoplasms, Unknown Primary
  
• Bevacizumab and Erlotinib in Treating Patients With Advanced Liver Cancer
  ClinicalTrials.gov Identifier: NCT00365391 - Recruiting
  Liver Cancer
  
• Bevacizumab and Erlotinib in Treating Patients With Metastatic or Unresectable Biliary Tumors
  ClinicalTrials.gov Identifier: NCT00356889 - Recruiting
  Extrahepatic Bile Duct Cancer; Gallbladder Cancer
  
• Bevacizumab and Erlotinib in Treating Patients With Metastatic Pancreatic Cancer That Did Not Respond to Previous Treatment With Gemcitabine
  ClinicalTrials.gov Identifier: NCT00365144 - Recruiting
  Pancreatic Cancer
  
• Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00055913 - Active, not recruiting
  Head and Neck Cancer
  
• Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
  ClinicalTrials.gov Identifier: NCT00126542 - Active, not recruiting
  recurrent ovarian epithelial cancer; stage IV ovarian epithelial cancer; Fallopian Tube Cancer; peritoneal cavity cancer
  
• Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00091026 - Recruiting
  adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; ...
  
• Bevacizumab and Gemcitabine in Treating Patients With Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00028834 - Completed
  stage III pancreatic cancer; recurrent pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00126490 - Active, not recruiting
  Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00301990 - Recruiting
  Kidney Cancer
  
• Bevacizumab and Irinotecan in Treating Patients With Recurrent High-Grade Malignant Glioma That Progressed on Bevacizumab Alone
  ClinicalTrials.gov Identifier: NCT00393094 - Recruiting
  Brain and Central Nervous System Tumors
  
• Bevacizumab and Irinotecan in Treating Patients With Recurrent or Refractory Gliomas
  ClinicalTrials.gov Identifier: NCT00268359 - Active, not recruiting
  Adult Anaplastic Astrocytoma; Adult Anaplastic Oligodendroglioma; Adult Glioblastoma; Adult Gliosarcoma; Recurrent Adult Brain Tumor; ...
  
• Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, or Ependymoma
  ClinicalTrials.gov Identifier: NCT00381797 - Recruiting
  Brain and Central Nervous System Tumors
  
• Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
  ClinicalTrials.gov Identifier: NCT00433381 - Suspended
  Brain and Central Nervous System Tumors
  
• Bevacizumab and Letrozole in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00305825 - Active, not recruiting
  Breast Cancer
  
• Bevacizumab and Low-Dose Cyclophosphamide in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00072566 - Completed
  recurrent ovarian epithelial cancer; stage IV ovarian epithelial cancer; peritoneal cavity cancer
  
• Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00098787 - Recruiting
  recurrent colon cancer; stage IV colon cancer; recurrent rectal cancer; Stage IV rectal cancer; adenocarcinoma of the colon; ...
  
• Bevacizumab and PEG-Interferon alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors
  ClinicalTrials.gov Identifier: NCT00055809 - Completed
  recurrent gastrointestinal carcinoid tumor; metastatic gastrointestinal carcinoid tumor; regional gastrointestinal carcinoid tumor
  
• Bevacizumab and Photodynamic Therapy in Neovascular Age Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00347399 - Recruiting
  Age Related Macular Degeneration
  
• Bevacizumab and Radiation Therapy for Sarcomas
  ClinicalTrials.gov Identifier: NCT00356031 - Recruiting
  Soft Tissue Sarcoma; Fibrous Histiocytoma; Liposarcoma; Leiomyosarcoma; Fibrosarcoma; Synovial Sarcoma
  
• Bevacizumab and Retinal Vascular Occlusions
  ClinicalTrials.gov Identifier: NCT00347711 - Recruiting
  Edema Macular; Vascular Occlusion
  
• Bevacizumab and Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00387751 - Recruiting
  Melanoma (Skin)
  
• Bevacizumab and Sunitinib in Treating Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00357318 - Recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Bevacizumab and Trastuzumab (Herceptin®) in Treating Women With Relapsed or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00093535 - Recruiting
  recurrent breast cancer; stage IIIC breast cancer; stage IV breast cancer; stage IIIB breast cancer
  
• Bevacizumab as an Adjuvant for Resectable Ductal Adenocarcinoma of the Pancreas
  ClinicalTrials.gov Identifier: NCT00158392 - Recruiting
  
  
• Bevacizumab Combined With Either Docetaxel or Erlotinib Compared With Docetaxel Alone in Patients With Recurrent or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00098410 - Recruiting
  recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer; Adenocarcinoma of the Lung; ...
  
• Bevacizumab Erlotinib Study in Advanced Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00130520 - Recruiting
  Ovarian Neoplasms
  
• Bevacizumab Given With Either Anastrozole or Fulvestrant With Trastuzumab for Postmenopausal Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00405938 - Recruiting
  Breast Cancer; Breast Neoplasms
  
• Bevacizumab in Combination With Metronomic Temozolomide for Recurrent Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00501891 - Recruiting
  Glioblastoma Multiforme; Brain and Central Nervous System Tumors; Recurrent Malignant Glioma; Recurrent Glioblastoma Multiforme
  
• Bevacizumab in Combination with Temozolomide in Patients with Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00137774 - Active, not recruiting
  Metastatic Neuroendocrine Tumor; Neuroendocrine Tumor
  
• Bevacizumab in Combination With Verteporfin Reduced and Standard Fluence in the Treatment of Hemorrhaged Lesions in Neovascular AMD
  ClinicalTrials.gov Identifier: NCT00403442 - Recruiting
  Macular Degeneration
  
• Bevacizumab in Multiple Phase I Combinations
  ClinicalTrials.gov Identifier: NCT00543504 - Recruiting
  Advanced Cancer
  
• Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00492089 - Recruiting
  Brain and Central Nervous System Tumors; Head and Neck Cancer; Radiation Toxicity; Sarcoma
  
• Bevacizumab in Treating Patients Who Have Undergone First-Line Therapy for Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00544700 - Recruiting
  Colorectal Cancer
  
• Bevacizumab in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00416637 - Active, not recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Bevacizumab in Treating Patients With Angiosarcoma
  ClinicalTrials.gov Identifier: NCT00288015 - Suspended
  Sarcoma
  
• Bevacizumab in Treating Patients With Kaposi's Sarcoma
  ClinicalTrials.gov Identifier: NCT00058136 - Recruiting
  Sarcoma
  
• Bevacizumab in Treating Patients With Metastatic Breast or Colorectal Cancer Who Received Bevacizumab on a Phase II or Phase III Clinical Trial
  ClinicalTrials.gov Identifier: NCT00066560 - Completed
  stage IV breast cancer; recurrent breast cancer; stage IV colon cancer; Stage IV rectal cancer
  
• Bevacizumab in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00022048 - Completed
  atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; myelodysplastic and myeloproliferative disease; Myelodysplastic Syndromes
  
• Bevacizumab in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00016094 - Active, not recruiting
  recurrent adult diffuse large cell lymphoma; recurrent adult Burkitt's lymphoma; recurrent mantle cell lymphoma; anaplastic large cell lymphoma
  
• Bevacizumab in Treating Patients With Persistent or Recurrent Cancer of the Cervix
  ClinicalTrials.gov Identifier: NCT00025233 - Active, not recruiting
  recurrent cervical cancer; cervical squamous cell carcinoma
  
• Bevacizumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00022659 - Active, not recruiting
  stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Bevacizumab in Treating Patients With Recurrent Glioma
  ClinicalTrials.gov Identifier: NCT00290797 - Recruiting
  Brain and Central Nervous System Tumors
  
• Bevacizumab in Treating Patients With Recurrent or Persistent Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00301964 - Recruiting
  Endometrial Cancer
  
• Bevacizumab in Treating Patients With Recurrent or Progressive Glioma
  ClinicalTrials.gov Identifier: NCT00337207 - Recruiting
  Brain and Central Nervous System Tumors
  
• Bevacizumab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00290810 - Recruiting
  Leukemia
  
• Bevacizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00482495 - Suspended
  Multiple Myeloma and Plasma Cell Neoplasm
  
• Bevacizumab in Treating Patients With Relapsed Prostate Cancer That Did Not Respond to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00478413 - Recruiting
  Prostate Cancer
  
• Bevacizumab in Treating Patients With Unresectable Nonmetastatic Liver Cancer
  ClinicalTrials.gov Identifier: NCT00055692 - Active, not recruiting
  adult primary hepatocellular carcinoma; recurrent adult primary liver cancer; localized unresectable adult primary liver cancer
  
• Bevacizumab in Treating Young Patients With Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00085111 - Completed
  unspecified childhood solid tumor, protocol specific
  
• Bevacizumab or Cetuximab Combined With Gemcitabine, Capecitabine, and Radiation Therapy in Treating Patients With Pancreatic Cancer That Has Been Completely Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00305877 - Recruiting
  Pancreatic Cancer
  
• Bevacizumab Plus Capecitabine (Xeloda) in Patients With Untreated Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00203411 - Recruiting
  Colorectal Cancer
  
• Bevacizumab Plus Docetaxel and Doxorubicin in Treating Patients With Previously Untreated Inflammatory or Locally Advanced Stage IIB or Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00021086 - Completed
  Breast Cancer
  
• Bevacizumab Plus Fluorouracil and Leucovorin in Treating Patients With Locally Advanced or Metastatic Stage IV Colorectal Cancer That Has Progressed After Standard Chemotherapy
  ClinicalTrials.gov Identifier: NCT00066846 - Completed
  adenocarcinoma of the colon; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ...
  
• Bevacizumab Plus Gemcitabine, Docetaxel, Melphalan, and Carboplatin in Ovarian Cancer Patients
  ClinicalTrials.gov Identifier: NCT00583622 - Recruiting
  Ovarian Cancer
  
• Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00017394 - Completed
  Male Breast Cancer; stage IV breast cancer; recurrent breast cancer
  
• Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00016549 - No longer recruiting
  Breast Cancer
  
• Bevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative Patients
  ClinicalTrials.gov Identifier: NCT00055237 - Recruiting
  Kaposi's Sarcoma; HIV Infections; HIV Seronegativity
  
• Bevacizumab Versus Combined Bevacizumab and Triamcinolone for Refractory Diabetic Macular Edema; a Randomized Clinical Trial
  ClinicalTrials.gov Identifier: NCT00370422 - Active, not recruiting
  Diabetic Macular Edema
  
• Bevacizumab Versus Ranibizumab for Diabetic Retinopathy
  ClinicalTrials.gov Identifier: NCT00545870 - Recruiting
  Diabetic Retinopathy; Diabetic Macula Edema; Proliferative Diabetic Retinopathy
  
• Bevacizumab With Abraxane in Patients With Recurrent Ovarian/ Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00407563 - Recruiting
  Epithelial Ovarian Cancer; Primary Peritoneal Carcinoma
  
• Bevacizumab With Hormonal and Radiotherapy for High-Risk Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00349557 - Recruiting
  Prostate Cancer
  
• Bevacizumab with Or Without Cyclophosphamide and Methotrexate: a Pilot Study in Women with Operable Breast Cancer
  ClinicalTrials.gov Identifier: NCT00121134 - Recruiting
  Breast Cancer
  
• Bevacizumab With or Without Docetaxel in Treating Patients With Previously Treated Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00066677 - Active, not recruiting
  adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Bevacizumab With or Without Interferon alfa in Treating Patients With Metastatic Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00026221 - Recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Bevacizumab With or Without Thalidomide in Treating Patients With Relapsed or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00022607 - Completed
  refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Bevacizumab(Avastin) and RAD001(Everolimus)in the Treatment of Advanced Clear Cell Renal Carcinoma
  ClinicalTrials.gov Identifier: NCT00323739 - Active, not recruiting
  Kidney Cancer
  
• Bevacizumab(Avastin) Induced Hypertension and Correlation With Tumor Response, a Chart Review
  ClinicalTrials.gov Identifier: NCT00322725 - Active, not recruiting
  Cancer
  
• Bevacizumab, Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00387699 - Suspended
  Lung Cancer
  
• Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer
  ClinicalTrials.gov Identifier: NCT00408694 - Recruiting
  Head and Neck Cancer
  
• Bevacizumab, Cytarabine, and Mitoxantrone on Treating Patients With Hematologic Cancers
  ClinicalTrials.gov Identifier: NCT00015951 - Active, not recruiting
  recurrent adult acute myeloid leukemia; relapsing chronic myelogenous leukemia; blastic phase chronic myelogenous leukemia; ...
  
• Bevacizumab, Dacarbazine and Interferon-Alfa to Treat Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00308607 - Recruiting
  Metastatic Melanoma
  
• Bevacizumab, Docetaxel, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00281840 - Recruiting
  Head and Neck Cancer
  
• Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer
  ClinicalTrials.gov Identifier: NCT00436709 - Active, not recruiting
  Breast Cancer
  
• Bevacizumab, Erlotinib and 5-Fluorouracil With External Beam Radiation Therapy in Locally Advanced Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00307736 - Recruiting
  Rectal Cancer; Adenocarcinoma of the Rectum
  
• Bevacizumab, Erlotinib, and Capecitabine for Locally Advanced Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00543842 - Recruiting
  Rectal Cancer
  
• Bevacizumab, Erlotinib, and Imatinib in the Treatment of Advanced Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00193258 - Active, not recruiting
  Prostate Cancer
  
• Bevacizumab, Everolimus, and Erlotinib in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00276575 - Active, not recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00052559 - Recruiting
  stage II rectal cancer; stage III rectal cancer; adenocarcinoma of the rectum
  
• Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00023959 - Active, not recruiting
  Head and Neck Cancer
  
• Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00112528 - Active, not recruiting
  duct cell adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer; recurrent pancreatic cancer
  
• Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00348998 - Recruiting
  Prostate Cancer
  
• Bevacizumab, Idarubicin, and Cytarabine in Treating Patients With Blast Phase Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00023920 - Completed
  blastic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia
  
• Bevacizumab, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Stage II or Stage III Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00410605 - Recruiting
  Multiple Myeloma and Plasma Cell Neoplasm
  
• Bevacizumab, Oxaliplatin, and Docetaxel in Treating Patients With Locally Advanced Unresectable or Metastatic Stomach or Gastroesophageal Junction Cancer
  ClinicalTrials.gov Identifier: NCT00217581 - Recruiting
  Esophageal Cancer; Gastric Cancer
  
• Bevacizumab, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00025389 - Completed
  stage I non-small cell lung cancer; stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer
  
• Bevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00369551 - Active, not recruiting
  Lung Cancer
  
• Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00369122 - Recruiting
  Cervical Cancer
  
• Bevacizumab, Radiation Therapy, and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Nonmetastatic Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00321685 - Recruiting
  Colorectal Cancer
  
• Bevacizumab, Sorafenib, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00378703 - Recruiting
  Kidney Cancer
  
• Bevacizumab, Temozolomide, and Erlotinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma Previously Treated With Radiation Therapy and Temozolomide
  ClinicalTrials.gov Identifier: NCT00535249 - Recruiting
  Brain and Central Nervous System Tumors
  
• Bevacizumab/Docetaxel/Carboplatin in Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00271505 - Recruiting
  Non-Small Cell Lung Cancer; Lung Cancer
  
• Bevacizumab/Tarceva and Tarceva/Sulindac in Squamous Cell Carcinoma of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00392665 - Recruiting
  Squamous Cell Carcinoma of the Head and Neck (SCCHN)
  
• Bevicizumab (Avastin) Infusion for CNV Not Associated With AMD
  ClinicalTrials.gov Identifier: NCT00407719 - Active, not recruiting
  Choroidal Neovascularization; Degenerative Myopia; Pathological Myopia
  
• Bexarotene and Fenretinide as Addition to Antipsychotic Treatment in Schizophrenia Patients
  ClinicalTrials.gov Identifier: NCT00534898 - Not yet recruiting
  Schizophrenia; Schizoaffective Disorder; Cognition
  
• Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00425477 - Recruiting
  Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Bexarotene and Interferon alfa in Treating Patients With Cutaneous T-Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00030849 - Active, not recruiting
  stage I cutaneous T-cell lymphoma; stage II cutaneous T-cell lymphoma; stage III cutaneous T-cell lymphoma; stage IV cutaneous T-cell lymphoma; ...
  
• Bexarotene Augmentation of Antipsychotic Treatment for Chronic Schizophrenia
  ClinicalTrials.gov Identifier: NCT00535574 - Not yet recruiting
  Schizophrenia
  
• Bexarotene in Preventing Breast Cancer in Women at Genetic Risk
  ClinicalTrials.gov Identifier: NCT00055991 - Active, not recruiting
  Breast Cancer
  
• Bexarotene in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003752 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Bexarotene Treatment in Schizophrenia
  ClinicalTrials.gov Identifier: NCT00141947 - Recruiting
  Schizophrenia
  
• Bexarotene with Narrow-Band UVB for Psoriasis
  ClinicalTrials.gov Identifier: NCT00151008 - Active, not recruiting
  Psoriasis
  
• Bexarotene, Tretinoin, and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00514293 - Recruiting
  Lung Cancer
  
• Beyond Ageing: A Study for the Prevention of Depression, Cognitive Impairment and the Improvement of Knowledge About Mental Health
  ClinicalTrials.gov Identifier: NCT00214682 - Recruiting
  Depression; Depressive Disorder; Cognition
  
• BEYOND Follow-up: Betaferon®/Betaseron® Efficacy Yielding Outcomes of a New Dose
  ClinicalTrials.gov Identifier: NCT00459667 - Active, not recruiting
  Multiple Sclerosis
  
• BEYOND Study - Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients
  ClinicalTrials.gov Identifier: NCT00099502 - Active, not recruiting
  Multiple Sclerosis
  
• Bezafibrate Trial in CPT2 Deficiency
  ClinicalTrials.gov Identifier: NCT00336167 - Recruiting
  Carnitine Palmitoyl Transferase 2 Deficiency
  
• BG9588 (Anti-CD40L Antibody) to Treat Lupus Nephritis
  ClinicalTrials.gov Identifier: NCT00001789 - Completed